Enrico Pompili

Bologna, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Pre-Treatment Serum Albumin Concentration Predicts Clinical Benefit of Long-Term Albumin in Patients With Cirrhosis and Ascites.

Pre-Treatment Serum Albumin Concentration Predicts Clinical Benefit of Long-Term Albumin in Patients With Cirrhosis and Ascites.

Journal: United European gastroenterology journal

Published: February 11, 2026

Post-Translational Changes in Serum Albumin in Patients with Alcohol-Associated Hepatitis.

Post-Translational Changes in Serum Albumin in Patients with Alcohol-Associated Hepatitis.

Journal: International journal of molecular sciences

Published: November 27, 2025

Personalised Long-Term Albumin Treatment Based on Three-Month Ascites Response in Patients With Decompensated Cirrhosis.

Personalised Long-Term Albumin Treatment Based on Three-Month Ascites Response in Patients With Decompensated Cirrhosis.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: October 14, 2025

Incidence and implications of abstinence-induced recompensation in alcohol-related cirrhosis.

Incidence and implications of abstinence-induced recompensation in alcohol-related cirrhosis.

Journal: Journal of hepatology

Published: July 08, 2025

Incidence and implications of abstinence-induced recompensation in alcohol-related cirrhosis.

Incidence and implications of abstinence-induced recompensation in alcohol-related cirrhosis.

Journal: Journal of hepatology

Published: July 08, 2025

Simvastatin and Rifaximin in Decompensated Cirrhosis: A Randomized Clinical Trial.

Simvastatin and Rifaximin in Decompensated Cirrhosis: A Randomized Clinical Trial.

Journal: JAMA

Published: February 05, 2025

Managing Multiorgan Failure in Acute on Chronic Liver Failure.

Managing Multiorgan Failure in Acute on Chronic Liver Failure.

Journal: Seminars in liver disease

Published: October 23, 2024

The burden of hepatic encephalopathy and the use of albumin as a potential treatment.

The burden of hepatic encephalopathy and the use of albumin as a potential treatment.

Journal: Annals of hepatology

Published: September 10, 2024

Validation and expansion of Baveno VII recompensation criteria in patients with cirrhosis and curable liver disease.

Validation and expansion of Baveno VII recompensation criteria in patients with cirrhosis and curable liver disease.

Journal: Journal of hepatology

Published: August 15, 2024

Real-world experience with long-term albumin in patients with cirrhosis and ascites.

Real-world experience with long-term albumin in patients with cirrhosis and ascites.

Journal: JHEP reports : innovation in hepatology

Published: May 07, 2024

Long-term albumin improves the outcomes of patients with decompensated cirrhosis and diabetes mellitus: Post hoc analysis of the ANSWER trial.

Long-term albumin improves the outcomes of patients with decompensated cirrhosis and diabetes mellitus: Post hoc analysis of the ANSWER trial.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: April 04, 2024

Myosteatosis is closely associated with sarcopenia and significantly worse outcomes in patients with cirrhosis.

Myosteatosis is closely associated with sarcopenia and significantly worse outcomes in patients with cirrhosis.

Journal: Journal of hepatology

Published: February 11, 2024

Showing 1-12 of 22

Last Updated: 09/26/2026